Maryland Senate Bill 1039 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on March 4 2019 - 25% progression, died in chamber
Action: 2019-03-20 - Unfavorable Report by Finance; Withdrawn
Text: Latest bill text (Introduced) [PDF]

Requiring the Maryland Medical Assistance Program to establish reimbursement levels, rather than maximum reimbursement levels, for certain drug products; requiring that certain minimum reimbursement levels be at least equal to the National Average Drug Acquisition Cost of the generic product plus a certain fee-for-service professional dispensing fee; providing that certain provisions of the Act apply to managed care organizations that use pharmacy benefits managers to manage prescription drug coverage; etc.

Maryland Medical Assistance Program and Managed Care Organizations That Use Pharmacy Benefits Managers - Reimbursement Requirements

Sen. Edward Reilly [R]

Date	Chamber	Action
2019-03-20	Senate	Unfavorable Report by Finance; Withdrawn
2019-03-18	Senate	Hearing canceled
2019-03-15	Senate	Hearing 3/19 at 1:00 p.m.
2019-03-14	Senate	Rereferred to Finance
2019-03-04	Senate	First Reading Senate Rules

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/SB1039?ys=2019rs
Text	https://mgaleg.maryland.gov/2019RS/bills/sb/sb1039f.pdf
Supplement	https://mgaleg.maryland.gov/2019RS/fnotes/bil_0009/sb1039.pdf
Supplement	https://mgaleg.maryland.gov/2019RS/votes_comm/sb1039_fin.pdf